Efficacy predictions for omalizumab treatment based on basophil CD203c expression in patients with allergic rhinitis by basophil activation test -- a real-life, pilot study. [PDF]
World Allergy Organ JZhao Z +5 more
europepmc +1 more source
MicroRNAs as current diagnostic biomarkers and potential therapeutic targets in allergic and non-allergic rhinitis - A functional characterization. [PDF]
Curr Allergy Asthma RepPrzychodniak D +2 more
europepmc +1 more source
Comparison of the efficacy of different doses of omalizumab (150 mg vs 300 mg) in patients with seasonal allergic rhinitis and low total IgE: A randomized, double-blind, controlled study. [PDF]
World Allergy Organ JLi L, Xu Y, Bian S, Pan Z, Guan K.
europepmc +1 more source
Assessment of Bronchodilator Responsiveness and Spirometric Patterns in Patients with Rhinitis and Suspected Asthma. [PDF]
J Asthma AllergyPan Z, Liu X, Li X, Guan K, Yin J.
europepmc +1 more source
Actual use of PROMs in asthma and rhinitis recommended by guidelines in clinical settings: PROMUSE respiratory study. [PDF]
Front AllergyCherrez-Ojeda I +28 more
europepmc +1 more source
Roles of Metabolomics in Allergic Rhinitis: From Cell to Bedside Investigations. [PDF]
Int J Mol SciSaligupta P +4 more
europepmc +1 more source
Seasonal allergic rhinitis in children: diagnostic markers of extreme allergic phenotype formation. [PDF]
Ital J PediatrKryuchko TO +5 more
europepmc +1 more source